Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Saúde (Santa Maria) |
Texto Completo: | https://periodicos.ufsm.br/revistasaude/article/view/63082 |
Resumo: | The damaging effects of Sars-CoV-2 on cardiac tissue may be intensified with the presence of cardiocirculatory pathologies. The use of clinical biomarkers has grown, in order to monitor this cardiotoxicity early. In this sense, this study aimed to investigate, through an integrative review, the main biomarkers of cardiac injury associated with comorbidities in patients with COVID-19. A systematic bibliographic search was conducted on July 26, 2020, in the Scopus database. Of the total of 669 publications purchased, only 40 articles were eligible for this review. From the content of these publications, 16 systemic cardiac and inflammatory biomarkers that are part of the clinical findings of critically ill patients with COVID-19 were identified. Most of these patients were male, had a mean age of 63 years, and pre-existing comorbidities, such as were hypertension, diabetes mellitus, coronary artery disease, cerebrovascular disease, and chronic obstructive pulmonary disease. Cardiac injuries in patients infected with COVID-19 are related to the increase in cardiac and systemic biomarkers observed in most of these individuals. Finally, it is expected to increase physicians' awareness of biochemical markers of non-invasive cardiac injury, for diagnosis and prognosis, of unusual extrapulmonary pathophysiological presentations during infection by COVID-19. |
id |
UFSM-14_8cd95d11ee2a4900639d2d51f156ddb5 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/63082 |
network_acronym_str |
UFSM-14 |
network_name_str |
Saúde (Santa Maria) |
repository_id_str |
|
spelling |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review.BiomarkersCardiac tissueComorbiditiesCOVID-19Myocardial injurySARS-CoV-2.The damaging effects of Sars-CoV-2 on cardiac tissue may be intensified with the presence of cardiocirculatory pathologies. The use of clinical biomarkers has grown, in order to monitor this cardiotoxicity early. In this sense, this study aimed to investigate, through an integrative review, the main biomarkers of cardiac injury associated with comorbidities in patients with COVID-19. A systematic bibliographic search was conducted on July 26, 2020, in the Scopus database. Of the total of 669 publications purchased, only 40 articles were eligible for this review. From the content of these publications, 16 systemic cardiac and inflammatory biomarkers that are part of the clinical findings of critically ill patients with COVID-19 were identified. Most of these patients were male, had a mean age of 63 years, and pre-existing comorbidities, such as were hypertension, diabetes mellitus, coronary artery disease, cerebrovascular disease, and chronic obstructive pulmonary disease. Cardiac injuries in patients infected with COVID-19 are related to the increase in cardiac and systemic biomarkers observed in most of these individuals. Finally, it is expected to increase physicians' awareness of biochemical markers of non-invasive cardiac injury, for diagnosis and prognosis, of unusual extrapulmonary pathophysiological presentations during infection by COVID-19.Universidade Federal de Santa Maria2021-03-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.ufsm.br/revistasaude/article/view/6308210.5902/2236583463082Saúde (Santa Maria); Revista Saúde (Santa Maria). 2021, v. 47, n. 1Saúde (Santa Maria); Revista Saúde (Santa Maria). 2021, v. 47, n. 12236-58340103-4499reponame:Saúde (Santa Maria)instname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMenghttps://periodicos.ufsm.br/revistasaude/article/view/63082/pdfCopyright (c) 2021 Saúde (Santa Maria)info:eu-repo/semantics/openAccessSoares, Wagner Rodrigues de AssisAndrade, Máyra Beatriz AlvesOliveira, Anne Araújo de JesusBrito, Pedro Gabriel SantosMiranda, Gabriel NovaesCardoso, Diego RochaSantos, Naiane OliveiraAndrade, Bruno Silva2021-03-23T22:27:03Zoai:ojs.pkp.sfu.ca:article/63082Revistahttps://periodicos.ufsm.br/revistasaudePUBhttps://periodicos.ufsm.br/revistasaude/oairevistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com2236-58342236-5834opendoar:2021-03-23T22:27:03Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM)false |
dc.title.none.fl_str_mv |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. |
title |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. |
spellingShingle |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. Soares, Wagner Rodrigues de Assis Biomarkers Cardiac tissue Comorbidities COVID-19 Myocardial injury SARS-CoV-2. |
title_short |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. |
title_full |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. |
title_fullStr |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. |
title_full_unstemmed |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. |
title_sort |
Laboratory biochemical markers of cardiac injury by COVID-19: an integrative review. |
author |
Soares, Wagner Rodrigues de Assis |
author_facet |
Soares, Wagner Rodrigues de Assis Andrade, Máyra Beatriz Alves Oliveira, Anne Araújo de Jesus Brito, Pedro Gabriel Santos Miranda, Gabriel Novaes Cardoso, Diego Rocha Santos, Naiane Oliveira Andrade, Bruno Silva |
author_role |
author |
author2 |
Andrade, Máyra Beatriz Alves Oliveira, Anne Araújo de Jesus Brito, Pedro Gabriel Santos Miranda, Gabriel Novaes Cardoso, Diego Rocha Santos, Naiane Oliveira Andrade, Bruno Silva |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Soares, Wagner Rodrigues de Assis Andrade, Máyra Beatriz Alves Oliveira, Anne Araújo de Jesus Brito, Pedro Gabriel Santos Miranda, Gabriel Novaes Cardoso, Diego Rocha Santos, Naiane Oliveira Andrade, Bruno Silva |
dc.subject.por.fl_str_mv |
Biomarkers Cardiac tissue Comorbidities COVID-19 Myocardial injury SARS-CoV-2. |
topic |
Biomarkers Cardiac tissue Comorbidities COVID-19 Myocardial injury SARS-CoV-2. |
description |
The damaging effects of Sars-CoV-2 on cardiac tissue may be intensified with the presence of cardiocirculatory pathologies. The use of clinical biomarkers has grown, in order to monitor this cardiotoxicity early. In this sense, this study aimed to investigate, through an integrative review, the main biomarkers of cardiac injury associated with comorbidities in patients with COVID-19. A systematic bibliographic search was conducted on July 26, 2020, in the Scopus database. Of the total of 669 publications purchased, only 40 articles were eligible for this review. From the content of these publications, 16 systemic cardiac and inflammatory biomarkers that are part of the clinical findings of critically ill patients with COVID-19 were identified. Most of these patients were male, had a mean age of 63 years, and pre-existing comorbidities, such as were hypertension, diabetes mellitus, coronary artery disease, cerebrovascular disease, and chronic obstructive pulmonary disease. Cardiac injuries in patients infected with COVID-19 are related to the increase in cardiac and systemic biomarkers observed in most of these individuals. Finally, it is expected to increase physicians' awareness of biochemical markers of non-invasive cardiac injury, for diagnosis and prognosis, of unusual extrapulmonary pathophysiological presentations during infection by COVID-19. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-03-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.ufsm.br/revistasaude/article/view/63082 10.5902/2236583463082 |
url |
https://periodicos.ufsm.br/revistasaude/article/view/63082 |
identifier_str_mv |
10.5902/2236583463082 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://periodicos.ufsm.br/revistasaude/article/view/63082/pdf |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Saúde (Santa Maria) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Saúde (Santa Maria) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Santa Maria |
publisher.none.fl_str_mv |
Universidade Federal de Santa Maria |
dc.source.none.fl_str_mv |
Saúde (Santa Maria); Revista Saúde (Santa Maria). 2021, v. 47, n. 1 Saúde (Santa Maria); Revista Saúde (Santa Maria). 2021, v. 47, n. 1 2236-5834 0103-4499 reponame:Saúde (Santa Maria) instname:Universidade Federal de Santa Maria (UFSM) instacron:UFSM |
instname_str |
Universidade Federal de Santa Maria (UFSM) |
instacron_str |
UFSM |
institution |
UFSM |
reponame_str |
Saúde (Santa Maria) |
collection |
Saúde (Santa Maria) |
repository.name.fl_str_mv |
Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM) |
repository.mail.fl_str_mv |
revistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com |
_version_ |
1799944002358738944 |